Maiwald Magazine

News and Releases

Maiwald Blog

15 Jun 2026 - Maiwald Blog

Shedding Light on the Black Box — AI Inventions under the Scrutiny of Art. 83 EPC

Six decisions of the EPO's Boards of Appeal use a string of cautionary tales to map the absolute floor of what patent applications for AI inventions must disclose — and ...

Continue reading

10 Jun 2026 - Maiwald Blog

File Late, Pay Licence

GPS spoofing, dual-use technology and the intellectual property question European developers must now ask

Continue reading

24 Apr 2026 - Maiwald Blog

Analysis of Examination Standards and Case Law for AI and Software-Related Inventions

I am very honored to announce that I have had the opportunity to write a book in Japanese, which has been published. The b...

Continue reading

All articles

Press Coverage

22 Jul 2026 - Press Coverage

Maiwald advises Royalty Pharma on the acquisition of royalty interests in AstraZeneca’s cliramitug

Maiwald advised Royalty Pharma on its acquisition of a portion of Neurimmune’s royalty interest in AstraZeneca’s investigational therapy cliramitug. The transaction is valued at up to USD 425 million, comprising an upfront payment of

Continue reading

5 Dec 2025 - Press Coverage

Royalty Pharma and Denali Therapeutics Announce $275 Million Royalty Funding Agreement.

Royalty Pharma and Denali have entered into a $275 million financing agreement which, pursuant to a synthetic royalty agreement, is based on future net sales of tividenofusp alfa. Tividenofusp alfa is Denali’s lead investigational TransportVehicle™-enabled enzyme rep...

Continue reading

25 Aug 2025 - Press Coverage

Royalty Pharma acquires licence interest for Amgen’s Imdelltra – Maiwald advises on transaction

Royalty Pharma has acquired a royalty interest in Amgen's Imdelltra, an innovative BiTE antibody for the treatment of small cell lung cancer, from BeOne Medicines for an upfront payment of $885 million. The agreement allows BeOne to sell additional royalty rights in Imdelltr...

Continue reading

Maiwald in the press

Staff News

4 Aug 2026 - Staff News

EQE success: Dr Iris Müller and Matthias Kreuz admitted as European Patent Attorneys

We are delighted to congratulate Iris Müller and Matthia...

Continue reading

2 Mar 2026 - Staff News

Maiwald appoints Dr. Kerstin Wolff as Partner

Maiwald, one of Germany’s leading intellectual property law firms, has appointed Dr. Kerstin Wolff as Partner effective from 1 March 2026. This appointment further strengthe...

Continue reading

29 Jan 2026 - Staff News

Maiwald appoints Martina Boidol, Dr. Anja Fux, and Sebastian Herzog as managing partners

With retroactive effect from the beginning of the new year, Maiwald, one of Germany's leading intellectual property law firms, has appointed Martina Boidol, Dr. Anja Fux, and ...

Continue reading

All Staff News

Publications

7 Aug 2026 - Publication

The New Protection Instrument in European Pharmaceutical Law: The Transferable Data Exclusivity Voucher, Licensing Executives Society International

The publication examines the Transferable Data Exclusivity Voucher (TDEV) as one of the most innovative elements of the proposed reform of European pharmaceutical legislation....

Continue reading

3 Aug 2026 - Publication

Referral G 1_25 on description adaptation

Aus MAIinsight Issue 4

Continue reading

3 Aug 2026 - Publication

The art of surrendering

Aus MAIinsight Issue 5

Continue reading

All publications

Awards

17 Aug 2026 - Award

IAM Strategy 300: The World’s Leading IP Strategists 2026

We are delighted that IAM has once again recognised several Maiwald partners in the Strategy 300: The World’s Leading IP Strategists 2026 list. ...

Continue reading

25 Jun 2026 - Award

Managing IP honours Maiwald practitioners in the 2026 IP STARS, Rising Stars and Notable Practitioners rankings

We are delighted that numerous Maiwald practitioners have once again been recognised by Managing IP (MIP) in its 2026 IP STARS rankings.

Continue reading

25 Jun 2026 - Award

IP STARS 2026: Maiwald once again among the leading IP firms

We are very delighted to announce that Maiwald has once again been recognised by Managing IP (MIP) as one of the leading intellectual property law firms in Germany in the

Continue reading

All awards

Events

Tue.

15

15 Sep 2026 |Upcoming

Maiwald as Gold Partner at IP Litigation North America – Pharma & Biotech Patent Litigation

On 15–16 September 2026, the Pharma & Biotech Patent Litigation at IP Litigation North America will take place at the Royal Sonesta Boston, bringing together U.S. life sciences IP leaders to develop and refine effective patent litigation strategies. The Pharma & Biotech Patent Litigation track is the premier platform for in‑house counsel, patent litigators and ...

Continue reading

Mon.

21

21 Sep 2026 |Upcoming

Maiwald at the 10th Munich IP Forum

On 21–22 September 2026, the Munich IP Forum will once again bring together leading representatives from industry, private practice, the judiciary, and the patent profession in Munich. The event provides a platform for exchanging insights on the latest developments in European patent law, with a particular focus on the Unified Patent Cou...

Continue reading

Thu.

1

1 Oct 2026 |Upcoming

Maiwald invites you to the MAItalk in Düsseldorf

On October 1 2026, we warmly invite you to the MAItalk seminar in Düsseldorf. Look forward to engaging, practice‑oriented presentations and stimulating discussions in a collegial atmosphere - ideal for exchanging ideas with experts and peers. Catering will be provided throughout the event. ...

Continue reading

Tue.

13

13 Oct 2026 |Upcoming

Maiwald sponsoring BIOTECH SUMMIT AUSTRIA 2026 in Innsbruck

The BIOTECH SUMMIT AUSTRIA enters its next chapter: on 13–14 October 2026, the Austrian and international biotech community will meet in Innsbruck to discuss current developments, opportunities and challenges in the sector. The summit brings together leading figures from academia, industry, start‑ups, investment, policy and life‑science ecosystems – creating exactl...

Continue reading

All events